CD4 and HIV infectious disease: Currently, in cases of HIV infection, it is recommended that all individuals receive prophylactic therapy when the CD4+ T cell count falls below 200 cells per millimeter (Cillóniz et al., 2019; Kaplan et al., 2002; Limper et al., 2011).